From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists
Graphical abstract
References and notes (22)
Eur. J. Pharmacol.
(2002)et al.Eur. Respir. J.
(1995)- et al.
- et al.
Bioorg. Med. Chem. Lett.
(2011)et al.Bioorg. Med. Chem. Lett.
(2010)et al.J. Med. Chem.
(2010)et al.Bioorg. Med. Chem. Lett.
(2010)et al.Bioorg. Med. Chem. Lett.
(2009)et al.Bioorg. Med. Chem. Lett.
(2009)et al.J. Med. Chem.
(2009)et al.Bioorg. Med. Chem. Lett.
(2008)et al.Bioorg. Med. Chem. Lett.
(2007)et al.Bioorg. Med. Chem. Lett.
(2007) - Alcaraz, L.; Lister, A.; Pairaudeau, G. WO2007106016,...
- et al.
J. Med. Chem.
(2003) - Alcaraz, L.; Cadogan, E. B.; Connolly, S.; Nicholls, D. J.; Young, A. WO2009037503,...
- et al.
J. Am. Chem. Soc.
(1949) - et al.
Lancet
(2003)et al.Eur. Resp. J.
(2003) - et al.
Curr. Opin. Pulm. Med.
(2010) - et al.
Am. J. Respir. Crit. Care Med.
(2001)Respiration
(2001)et al.Am. J. Respir. Crit. Care Med.
(2001)et al.Chest
(1999)et al.Pulm. Pharmacol.
(1995)
Prog. Resp. Res.
(2010)
et al.Annu. Rep. Med. Chem.
(2006)
Cited by (15)
The API
2021, Inhaled Medicines: Optimizing Development through Integration of In Silico, In Vitro and In Vivo ApproachesThe identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1- hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β<inf>2</inf>-adrenoceptor agonist
2014, Bioorganic and Medicinal Chemistry LettersDiscovery of TD-4306, a long-acting β<inf>2</inf>-agonist for the treatment of asthma and COPD
2014, Bioorganic and Medicinal Chemistry LettersMultivalent design of long-acting β<inf>2</inf>-adrenoceptor agonists incorporating biarylamines
2014, Bioorganic and Medicinal Chemistry LettersSports doping: Emerging designer and therapeutic β<inf>2</inf>-agonists
2013, Clinica Chimica ActaCitation Excerpt :Finally, other work identified compound c (Fig. 8) to be potent and efficacious at the β2-adrenoceptor, to have good selectivity over closely related receptors and long duration of action in a bronchoconstriction guinea pig model, which is superior to that of both formoterol and salmeterol, and similar to that of indacaterol. Due to its promising profile, compound c of Fig. 8 (as the bis-malonate salt) was progressed into further development [90]. The research interest in the pharmaceutical industry has been currently directed to the development of Ultra-LABAs with improved duration of action over the most used LABAs, salmeterol and formoterol.
Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs for Extending the Lung Tissue Retention of Inhaled Drugs
2022, Journal of Medicinal Chemistry
Copyright © 2011 Elsevier Ltd. All rights reserved.